A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
Crossref DOI link: https://doi.org/10.1186/1471-2466-14-192
Published Online: 2014-12-04
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lange, Ansgar
Prenzler, Anne
Frank, Martin
Golpon, Heiko
Welte, Tobias
von der Schulenburg, J-Matthias
License valid from 2014-12-01
Article History
Received: 25 July 2013
Accepted: 20 November 2014
First Online: 4 December 2014